Back
Digital Ally 10K Form
Sell
30
DGLY
Digital Ally
Last Price:
1.18
Seasonality Move:
-5.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-17 | 10Q | DGLY/Digital Ally Quarterly |
2023-11-14 | 10Q | DGLY/Digital Ally Quarterly |
2023-08-14 | 10Q | DGLY/Digital Ally Quarterly |
2023-05-15 | 10Q | DGLY/Digital Ally Quarterly |
2022-12-09 | 10Q | DGLY/Digital Ally Quarterly |
2022-11-14 | 10Q | DGLY/Digital Ally Quarterly |
Receive DGLY News And Ratings
See the #1 stock for the next 7 days that we like better than DGLY
DGLY Financial Statistics
Sales & Book Value
Annual Sales: | $28.25M |
---|---|
Cash Flow: | $-2.5M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.66 |
Price / Book: | 1.73 |
Profitability
EPS (TTM): | -7.10000 |
---|---|
Net Income (TTM): | $-20.2M |
Gross Margin: | $5.76M |
Return on Equity: | -159.44% |
Return on Assets: | -42.03% |
Digital Ally Earnings Forecast
Key Digital Ally Financial Ratios
- The Gross Profit Margin over the past 18 years for DGLY is 20.40%.
- The Selling, General & Administrative Expenses for DGLY have been equal to 89.86% of Gross Profit Margin.
- The Research & Development expenses have been 9.27% of Revenue.
- The Interest Expense is -12.20% of Operating Income.
- The Net Earning history of DGLY is -90.94% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 10 years.
Digital Ally Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Electronic Equipment, Instruments & Components |
Sector: | Information Technology |
Current Symbol: | DGLY |
CUSIP: | 25382P |
Website: | digitalallyinc.com |
Debt
Debt-to-Equity Ratio: | 4.57 |
---|---|
Current Ratio: | 0.51 |
Quick Ratio: | 0.2 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
DGLY Technical Analysis vs Fundamental Analysis
Sell
30
Digital Ally (DGLY)
is a Sell
Is Digital Ally a Buy or a Sell?
-
Digital Ally stock is rated a Sell
The current Digital Ally [DGLY] share price is $1.04. The Score for DGLY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.